BDTX Q2 2024 Earnings — Black Diamond Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

BDTXBlack Diamond Therapeutics, Inc.

$126M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$86,000

Operating Income

-$22M

Net Income

-$20M

EPS (Diluted)

$-0.36

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$15M

Free Cash Flow

$0

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$150M

Total Liabilities

$39M

Stockholders' Equity

$111M

Cash & Equivalents

$33M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$86,000	$0	—
Operating Income	-$22M	-$20M	-10.5%
Net Income	-$20M	-$19M	-4.0%